Clinical Trials Logo

Wounds and Injuries clinical trials

View clinical trials related to Wounds and Injuries.

Filter by:

NCT ID: NCT04948476 Recruiting - Acute Kidney Injury Clinical Trials

Promoting Kidney Recovery After Acute Kidney Injury Receiving Dialysis

Recover-AKI
Start date: April 12, 2022
Phase: N/A
Study type: Interventional

The overall goal of this study is to evaluate the feasibility of conducting a randomized controlled trial comparing a standardized dialysis strategy versus usual care (dialysis prescription ordered by each patient's primary nephrologist) in patients with AKI-receiving dialysis.

NCT ID: NCT04946747 Not yet recruiting - Concussion Clinical Trials

Detection and Prevention of Concussive Injuries With Smart Technology.

Start date: June 2021
Phase: N/A
Study type: Interventional

Concussions are consequences of inopportune interactions between an impact force and the head that causes the head (and brain) to move too rapidly. This project involves two parts. 1. The outcome of head-impact depends upon the force and the biomechanical properties of the head-and-neck. Modern microelectrical mechanical systems (MEMS) head-impact sensors only measure the physical parameters of external forces. The researchers have developed a next-generation smart MEMS sensor fortified with artificial intelligence (AI) that can help define a personalized concussive threshold. The researchers sensor machine-learns the biomechanical properties of the participant's head-and-neck and accurately determines the likelihood for concussive injuries. The researchers first goal is to field-test the sensor in soccer players. 2. Researchers hypothesize that an increase in neck stiffness should reduce concussive risks. The researchers have developed a training protocol that involves a conditioned response (CR) to increase neck stiffness during a head-impact event and thereby decrease concussion risk. The Researchers have also developed technology to monitor neck stiffness. The smart sensor is fully integrated into the training protocol and monitors the neck stiffness to validate the effectiveness of the training. The second goal is to optimize and finalize our training protocol and conduct a field-test in soccer players.

NCT ID: NCT04946422 Recruiting - Sports Injury Clinical Trials

Chinese Sports Injury Treatment Situation and Development Trend of Big Data Research

Start date: January 2013
Phase:
Study type: Observational

This project is planned to be based on the medical insurance database collected by the China Health Insurance Research Association (CHIRA). As a national academic research institution, CHIRA collects medical insurance patient data, covering more than 20 provinces across the country. The data of more than 60 municipalities, provincial capitals, and prefecture-level cities are unique and authoritative in my country. Based on the CHIRA database, big data analysis for Chinese sports medicine patients, starting from the names of medical institutions, admission/discharge diagnosis and classification of medical items, etc., to investigate the development trend of arthroscopic surgery in China and understand my country's arthroscopic diseases The distribution characteristics and changing trends of the quantity.

NCT ID: NCT04945213 Recruiting - Clinical trials for Brain Injury Traumatic Severe

Biperiden Trial for Epilepsy Prevention

BIPERIDEN
Start date: January 10, 2023
Phase: Phase 3
Study type: Interventional

One of the most important neurological consequences following Traumatic Brain Injury (TBI) is the development of post traumatic epilepsy (PTE). Nevertheless, there is still no effective therapeutic intervention to reduce the occurrence of PTE. In previous studies with animals models of epilepsy, the biperiden decreased the incidence and intensity of spontaneous epileptic seizures besides delaying their appearance. The aim of this study is the evaluation of biperiden as antiepileptogenic drug to prevent PTE and also the determination of side effects, evaluating its cost-effectiveness in patients with moderate and severe TBI.

NCT ID: NCT04944537 Active, not recruiting - Trauma Injury Clinical Trials

Current Situation and Analysis of ICU Management for Severe Trauma Patients in China

NJJLISTP
Start date: May 27, 2021
Phase:
Study type: Observational

Over the past 10 years, there has not been a consensus on ICU nursing management based on the concept of injury control. Case management for patients with serious trauma continues to be initiated in general services and after discharge.There is no critical care unit case management strategy for the high-risk population following acute intake. Consequently, there is an urgent need to develop and enhance ICU nursing best practice after injury control.

NCT ID: NCT04944355 Not yet recruiting - Clinical trials for Urinary Tract Injuries During Caesarean Section for Morbidly Adherent Placenta: Prospective and Retrospective Study

Urinary Tract Injuries During Caesarean Section for Morbidly Adherent Placenta: Prospective and Retrospective Study

Start date: June 2021
Phase:
Study type: Observational

M1- evaluates the cases of lower urinary tract injuries during caesarean section with or without hysterectomy in cases with morbid placental adherence in the period between years 2018 and 2021. This study was carried out in assiut university women health hospital M 2- Clarification of the risk factors and outcome of urinary tract injuries.

NCT ID: NCT04944186 Completed - Pressure Injury Clinical Trials

Effect of Structured Pressure Injury Patient Education

SPIPE
Start date: July 8, 2021
Phase: N/A
Study type: Interventional

This study was planned as a prospective quasi-experimental study with the control group to determine the effect of structured pressure injury patient education (program on the knowledge, participation, wound healing progress, and quality of life among patients with limited mobility. We hypothesized that there would be a significant effect of structured pressure injury patient education on patient's knowledge, participation, wound healing rate, and quality of life between the control and intervention group over time.

NCT ID: NCT04943835 Completed - Clinical trials for Acquired Brain Injury

Validity of a Test of Functional Cognition in Persons With Acquired Brain Injury

Start date: January 12, 2017
Phase:
Study type: Observational

The purpose of this study is to test the validity of the Weekly Calendar Planning Activity (WCPA), a test of functional cognition in persons with acquired brain injury. We will formally examine the utility, baseline profile and validity of the WCPA with adults ages 21 and above with acquired brain injury for both the WCPA 17 and WCPA 10 versions.

NCT ID: NCT04941625 Recruiting - Acute Kidney Injury Clinical Trials

Risk of Acute Kidney Injury in Patients Undergoing Cytoreductive Surgery and Hyperthermic Intra-peritoneal Chemotherapy

Start date: February 23, 2018
Phase:
Study type: Observational

Background: Cytoreductive surgery with hyperthermic intraperitoneal chemotherapy (HIPEC) is an emerging surgical procedure for peritoneal carcinomatosis. Despite the survival benefits from HIPEC, complications have been reported with major morbidity and mortality. Acute kidney injury (AKI) is one of the major complications. To date, there is no adequate biomarker to predict the risk of AKI after HIPEC and monitor the renal prognosis after HIPEC-related AKI. Aims: 1. Establish a HIPEC cohort database, including retrospective data and prospective database 2. Identify the incidence of AKI after HIPEC and the severity 3. Identify the biomarker to predictive HIPEC-related AKI and monitor renal prognosis. Understand the risk factors for AKI post- HIPEC helps improve pre-operative patient selection and optimization, facilitate tailoring of chemotherapy, and foster closer peri-operative monitoring and fluid management in at-risk patients. Methods: 1. Patients with the peritoneal carcinomatosis, planning to receive HIPEC and agree to participate the study will be recruited. 2. Retrospective analyze the renal prognosis of patients with HIPEC procedure and identify the clinical and biochemistry risk factors of HIPEC-related AKI 3. Prospective collect the information of patients who are enrolled into this study. The information includes clinical information, biochemistry, electrolyte, and novel biomarkers of body fluids (blood, and urine). The samples of body fluids will be collected on pre-operative day, post-operative 2h, 24h, 48h, 72h and day 7. Patients with or without post-HIPEC AKI will be analyzed. Hypothesis: 1. Peri-operative dehydration and cisplatin-based regimen are the major risk factors to cause AKI. 2. The novel biomarker, high peri-operative urine NGAL and serum cystatin C, β2 Microglobulin are the predictive markers of HIPEC- related AKI.

NCT ID: NCT04940676 Recruiting - Sepsis Clinical Trials

Oral Administration or Nasal Feeding of Huzhangxiefei Decoction for Treatment in Sepsis Induced Acute Lung Injury

Start date: March 10, 2021
Phase: Phase 2
Study type: Interventional

Hypothesis 1A: Oral Administration or Nasal Feeding of Huzhangxiefei Decoction will significantly attenuate sepsis-induced systemic organ failure as measured by overall response rate. Hypothesis 1B: Oral Administration or Nasal Feeding of Huzhangxiefei Decoction will attenuate sepsis-induced lung injury as assessed by the respiratory rate and oxygenation index. Hypothesis 1C: Oral Administration or Nasal Feeding of Huzhangxiefei Decoction will attenuate sepsis-induced lung injury as assessed by chest x-ray scale score, Chinese Medicine scale score. Hypothesis 1D: Oral Administration or Nasal Feeding of Huzhangxiefei Decoction will attenuate biomarkers of inflammation (C-Reactive Protein, Procalcitonin), vascular injury (Thrombomodulin, Angiopoietin-2), alveolar epithelial injury (Receptor for Advanced Glycation Products), while inducing the onset of a fibrinolytic state (Tissue Factor Pathway Inhibitor).